In this webcast, Dr. Richard Shaffer presents on a range of clinical conditions that can be treated with superficial-orthovoltage radiotherapy machines. The presentation primarily focuses on the treatment of non-melanoma skin cancer, including several illustrative cases. It also includes information on palliative indications and benign indications, including treatment of benign musculoskeletal and skin conditions.
XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.
Xstrahl’s XBeam has received FDA 510(k) Clearance for Use in the U.S. The XBeam technology streamlines radiotherapy treatment planning and simplifies patient workflow for treating skin cancer, benign diseases, and palliative care. Explore how this innovation enhances orthovoltage superficial radiotherapy (SRT) and electronic brachytherapy (eBt). With XBeam, you can calculate, protocol and export treatment plans for Xstrahl treatments with Radiant Aura and all other Xstrahl medical devices in the U.S. and worldwide.
